2112 Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI + cetuximab once every 2 weeks in the APEC study. (September 2015) - Cheng, A.L.; Cornelio, G.H.; Shen, L.; Price, T.J.; Yang, T.S.; Chung, I.J.; Dai, G.; Lin, J.K.; Sharma, A.; Yeh, K.H.; Ma, B.; Zaatar, A.; et al.